Figure 1. EXTEND study: response in histologically confirmed aggressive B-cell non-Hodgkin lymphoma (+ prior rituximab), post hoc analysis20
Figure_1_02
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.